Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique
Display Omitted
Gespeichert in:
| Autor*in: |
Zu, Yuangang [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2014 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
11 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides - Nigolian, H. ELSEVIER, 2022, New York, NY [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:471 ; year:2014 ; number:1 ; day:25 ; month:08 ; pages:366-376 ; extent:11 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ijpharm.2014.05.049 |
|---|
| Katalog-ID: |
ELV022735356 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV022735356 | ||
| 003 | DE-627 | ||
| 005 | 20230623164640.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ijpharm.2014.05.049 |2 doi | |
| 028 | 5 | 2 | |a GBVA2014012000004.pica |
| 035 | |a (DE-627)ELV022735356 | ||
| 035 | |a (ELSEVIER)S0378-5173(14)00402-5 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.61 |2 bkl | ||
| 100 | 1 | |a Zu, Yuangang |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique |
| 264 | 1 | |c 2014 | |
| 300 | |a 11 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Display Omitted | ||
| 650 | 7 | |a Nanoparticles |2 Elsevier | |
| 650 | 7 | |a Antioxidant ability |2 Elsevier | |
| 650 | 7 | |a Dissolution rate |2 Elsevier | |
| 650 | 7 | |a Taxifolin |2 Elsevier | |
| 650 | 7 | |a LAP |2 Elsevier | |
| 650 | 7 | |a Bioavailability |2 Elsevier | |
| 700 | 1 | |a Wu, Weiwei |4 oth | |
| 700 | 1 | |a Zhao, Xiuhua |4 oth | |
| 700 | 1 | |a Li, Yong |4 oth | |
| 700 | 1 | |a Wang, Weiguo |4 oth | |
| 700 | 1 | |a Zhong, Chen |4 oth | |
| 700 | 1 | |a Zhang, Yin |4 oth | |
| 700 | 1 | |a Zhao, Xue |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Nigolian, H. ELSEVIER |t Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |d 2022 |g New York, NY [u.a.] |w (DE-627)ELV008932840 |
| 773 | 1 | 8 | |g volume:471 |g year:2014 |g number:1 |g day:25 |g month:08 |g pages:366-376 |g extent:11 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ijpharm.2014.05.049 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.61 |j Innere Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 471 |j 2014 |e 1 |b 25 |c 0825 |h 366-376 |g 11 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
y z yz |
|---|---|
| matchkey_str |
zuyuangangwuweiweizhaoxiuhualiyongwangwe:2014----:nacmnoslbltatoiatbltadiaalbltotxflnaoatceblqia |
| hierarchy_sort_str |
2014 |
| bklnumber |
44.61 |
| publishDate |
2014 |
| allfields |
10.1016/j.ijpharm.2014.05.049 doi GBVA2014012000004.pica (DE-627)ELV022735356 (ELSEVIER)S0378-5173(14)00402-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Zu, Yuangang verfasserin aut Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticles Elsevier Antioxidant ability Elsevier Dissolution rate Elsevier Taxifolin Elsevier LAP Elsevier Bioavailability Elsevier Wu, Weiwei oth Zhao, Xiuhua oth Li, Yong oth Wang, Weiguo oth Zhong, Chen oth Zhang, Yin oth Zhao, Xue oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:471 year:2014 number:1 day:25 month:08 pages:366-376 extent:11 https://doi.org/10.1016/j.ijpharm.2014.05.049 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 471 2014 1 25 0825 366-376 11 045F 610 |
| spelling |
10.1016/j.ijpharm.2014.05.049 doi GBVA2014012000004.pica (DE-627)ELV022735356 (ELSEVIER)S0378-5173(14)00402-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Zu, Yuangang verfasserin aut Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticles Elsevier Antioxidant ability Elsevier Dissolution rate Elsevier Taxifolin Elsevier LAP Elsevier Bioavailability Elsevier Wu, Weiwei oth Zhao, Xiuhua oth Li, Yong oth Wang, Weiguo oth Zhong, Chen oth Zhang, Yin oth Zhao, Xue oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:471 year:2014 number:1 day:25 month:08 pages:366-376 extent:11 https://doi.org/10.1016/j.ijpharm.2014.05.049 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 471 2014 1 25 0825 366-376 11 045F 610 |
| allfields_unstemmed |
10.1016/j.ijpharm.2014.05.049 doi GBVA2014012000004.pica (DE-627)ELV022735356 (ELSEVIER)S0378-5173(14)00402-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Zu, Yuangang verfasserin aut Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticles Elsevier Antioxidant ability Elsevier Dissolution rate Elsevier Taxifolin Elsevier LAP Elsevier Bioavailability Elsevier Wu, Weiwei oth Zhao, Xiuhua oth Li, Yong oth Wang, Weiguo oth Zhong, Chen oth Zhang, Yin oth Zhao, Xue oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:471 year:2014 number:1 day:25 month:08 pages:366-376 extent:11 https://doi.org/10.1016/j.ijpharm.2014.05.049 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 471 2014 1 25 0825 366-376 11 045F 610 |
| allfieldsGer |
10.1016/j.ijpharm.2014.05.049 doi GBVA2014012000004.pica (DE-627)ELV022735356 (ELSEVIER)S0378-5173(14)00402-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Zu, Yuangang verfasserin aut Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticles Elsevier Antioxidant ability Elsevier Dissolution rate Elsevier Taxifolin Elsevier LAP Elsevier Bioavailability Elsevier Wu, Weiwei oth Zhao, Xiuhua oth Li, Yong oth Wang, Weiguo oth Zhong, Chen oth Zhang, Yin oth Zhao, Xue oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:471 year:2014 number:1 day:25 month:08 pages:366-376 extent:11 https://doi.org/10.1016/j.ijpharm.2014.05.049 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 471 2014 1 25 0825 366-376 11 045F 610 |
| allfieldsSound |
10.1016/j.ijpharm.2014.05.049 doi GBVA2014012000004.pica (DE-627)ELV022735356 (ELSEVIER)S0378-5173(14)00402-5 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.61 bkl Zu, Yuangang verfasserin aut Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique 2014 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Display Omitted Nanoparticles Elsevier Antioxidant ability Elsevier Dissolution rate Elsevier Taxifolin Elsevier LAP Elsevier Bioavailability Elsevier Wu, Weiwei oth Zhao, Xiuhua oth Li, Yong oth Wang, Weiguo oth Zhong, Chen oth Zhang, Yin oth Zhao, Xue oth Enthalten in Elsevier Nigolian, H. ELSEVIER Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides 2022 New York, NY [u.a.] (DE-627)ELV008932840 volume:471 year:2014 number:1 day:25 month:08 pages:366-376 extent:11 https://doi.org/10.1016/j.ijpharm.2014.05.049 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.61 Innere Medizin VZ AR 471 2014 1 25 0825 366-376 11 045F 610 |
| language |
English |
| source |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:471 year:2014 number:1 day:25 month:08 pages:366-376 extent:11 |
| sourceStr |
Enthalten in Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides New York, NY [u.a.] volume:471 year:2014 number:1 day:25 month:08 pages:366-376 extent:11 |
| format_phy_str_mv |
Article |
| bklname |
Innere Medizin |
| institution |
findex.gbv.de |
| topic_facet |
Nanoparticles Antioxidant ability Dissolution rate Taxifolin LAP Bioavailability |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| authorswithroles_txt_mv |
Zu, Yuangang @@aut@@ Wu, Weiwei @@oth@@ Zhao, Xiuhua @@oth@@ Li, Yong @@oth@@ Wang, Weiguo @@oth@@ Zhong, Chen @@oth@@ Zhang, Yin @@oth@@ Zhao, Xue @@oth@@ |
| publishDateDaySort_date |
2014-01-25T00:00:00Z |
| hierarchy_top_id |
ELV008932840 |
| dewey-sort |
3610 |
| id |
ELV022735356 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV022735356</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623164640.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2014.05.049</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014012000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV022735356</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(14)00402-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zu, Yuangang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanoparticles</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antioxidant ability</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dissolution rate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Taxifolin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bioavailability</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wu, Weiwei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Xiuhua</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Yong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Weiguo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhong, Chen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Yin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Xue</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:471</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">day:25</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:366-376</subfield><subfield code="g">extent:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2014.05.049</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">471</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="b">25</subfield><subfield code="c">0825</subfield><subfield code="h">366-376</subfield><subfield code="g">11</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Zu, Yuangang |
| spellingShingle |
Zu, Yuangang ddc 610 bkl 44.61 Elsevier Nanoparticles Elsevier Antioxidant ability Elsevier Dissolution rate Elsevier Taxifolin Elsevier LAP Elsevier Bioavailability Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique |
| authorStr |
Zu, Yuangang |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV008932840 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.61 bkl Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique Nanoparticles Elsevier Antioxidant ability Elsevier Dissolution rate Elsevier Taxifolin Elsevier LAP Elsevier Bioavailability Elsevier |
| topic |
ddc 610 bkl 44.61 Elsevier Nanoparticles Elsevier Antioxidant ability Elsevier Dissolution rate Elsevier Taxifolin Elsevier LAP Elsevier Bioavailability |
| topic_unstemmed |
ddc 610 bkl 44.61 Elsevier Nanoparticles Elsevier Antioxidant ability Elsevier Dissolution rate Elsevier Taxifolin Elsevier LAP Elsevier Bioavailability |
| topic_browse |
ddc 610 bkl 44.61 Elsevier Nanoparticles Elsevier Antioxidant ability Elsevier Dissolution rate Elsevier Taxifolin Elsevier LAP Elsevier Bioavailability |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
w w ww x z xz y l yl w w ww c z cz y z yz x z xz |
| hierarchy_parent_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| hierarchy_parent_id |
ELV008932840 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV008932840 |
| title |
Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique |
| ctrlnum |
(DE-627)ELV022735356 (ELSEVIER)S0378-5173(14)00402-5 |
| title_full |
Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique |
| author_sort |
Zu, Yuangang |
| journal |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| journalStr |
Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2014 |
| contenttype_str_mv |
zzz |
| container_start_page |
366 |
| author_browse |
Zu, Yuangang |
| container_volume |
471 |
| physical |
11 |
| class |
610 610 DE-600 610 VZ 44.61 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Zu, Yuangang |
| doi_str_mv |
10.1016/j.ijpharm.2014.05.049 |
| dewey-full |
610 |
| title_sort |
enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique |
| title_auth |
Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique |
| abstract |
Display Omitted |
| abstractGer |
Display Omitted |
| abstract_unstemmed |
Display Omitted |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| container_issue |
1 |
| title_short |
Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique |
| url |
https://doi.org/10.1016/j.ijpharm.2014.05.049 |
| remote_bool |
true |
| author2 |
Wu, Weiwei Zhao, Xiuhua Li, Yong Wang, Weiguo Zhong, Chen Zhang, Yin Zhao, Xue |
| author2Str |
Wu, Weiwei Zhao, Xiuhua Li, Yong Wang, Weiguo Zhong, Chen Zhang, Yin Zhao, Xue |
| ppnlink |
ELV008932840 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ijpharm.2014.05.049 |
| up_date |
2024-07-06T17:02:01.123Z |
| _version_ |
1803849900881870848 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV022735356</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623164640.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ijpharm.2014.05.049</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014012000004.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV022735356</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0378-5173(14)00402-5</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.61</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Zu, Yuangang</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Enhancement of solubility, antioxidant ability and bioavailability of taxifolin nanoparticles by liquid antisolvent precipitation technique</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Display Omitted</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanoparticles</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Antioxidant ability</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Dissolution rate</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Taxifolin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LAP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Bioavailability</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wu, Weiwei</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Xiuhua</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Li, Yong</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wang, Weiguo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhong, Chen</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhang, Yin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zhao, Xue</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Nigolian, H. ELSEVIER</subfield><subfield code="t">Description d’une cohorte française multicentrique de porteurs asymptomatiques d’anticorps anti-phospholipides</subfield><subfield code="d">2022</subfield><subfield code="g">New York, NY [u.a.]</subfield><subfield code="w">(DE-627)ELV008932840</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:471</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:1</subfield><subfield code="g">day:25</subfield><subfield code="g">month:08</subfield><subfield code="g">pages:366-376</subfield><subfield code="g">extent:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ijpharm.2014.05.049</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.61</subfield><subfield code="j">Innere Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">471</subfield><subfield code="j">2014</subfield><subfield code="e">1</subfield><subfield code="b">25</subfield><subfield code="c">0825</subfield><subfield code="h">366-376</subfield><subfield code="g">11</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.401742 |